Author Archives: admin

  • -
Palm Beach Event lunch with Charles Laverty

Palm Beach Event Luncheon Event by FON

We are pleased to announce a Palm Beach event luncheon held by Palm Beach Family Office Association.  The event will take place on November 7th at noon at the Flagler Steakhouse.

The event is Transforming Stenting Best Practice in Coronary Bifurcation Disease.   Our CEO, Charles Laverty will be presenting at the luncheon.

You may RSVP here.


  • -
Chief Executive Officer Charles Laverty to Speak at FON Luncheon

Charles Laverty To Speak At The FON Luncheon

Please Join Us

Come join Advanced Bifurcation Systems Chief Executive Officer Charles Laverty for a presentation on how the ABS Mother-Daughter platform is the only platform to treat all bifurcations.

The event is being held at Lucques in West Hollywood California on October 17th from noon until 2pm.

The event is being organized by Family Office Networks.  You may RSVP here.

Charles Laverty Presentation For

BIFURCATION DISEASE FOR A DISRUPTIVE TECHNOLOGY

8474 Melrose Avenue

West Hollywood, CA


  • -
Dick Cheney Joining Us At The TCT2018

Dick Cheney Will Be Joining Us At TCT2018

Dick Cheney Joining US

Advanced Bifurcation Systems is sponsoring a booth at the tct2018 convention in San Diego.  We are very honored to have Dick Cheney joining us at our booth.

The event is hosted by the Cardiovasculare Research Foundation.  The dates are Sepember 21st through the 25th.  You can find more information on the event by visiting this link.


  • -
Charles Laverty will present ABS at the Southern California Investor Conference on August 23rd in Newport Beach

ABS Presenting at SoCal Investor Conference August 23rd

Investors and Entrepreneurs provide the Fuel and Spark for Innovation

Charles Laverty will be accompanied by Ken Richards and others at noon this Thursday, August 23rd at the 2018 Southern California Investor Conference at the Balboa Bay Resort in Newport Beach.

Experts predict that the coronary stent market will reach $10B in 2025 and Bifurcation disease could be 25% of that. As Family Office Networks Founder Andrew Schneider announced recently, “We believe ABS is poised to capture a significant part of this $2.5B market as the only true and complete bifurcating stent delivery platform in the market.”

Conference Details

Southern California Investor Conference
12 noon
Thursday, August 23rd
Balboa Bay Resort, Newport Beach

  • -

ABS Announces California Manufacturing Center

Today Charles Laverty announced that Advanced Bifurcation Systems® will launch our global manufacturing facility in Livermore, California. In a blog post and article, Mr. Laverty stated that the location will create an estimated 35-50 new positions to start at ABS and it will serve as our initial global manufacturing hub.

The facility location has Class 10,000 Cleanrooms which are critical to our plan and will be certified to build and assemble the ABS Platform. Livermore was selected because it h some of the very best facilities in the world and because of its place as a top global hub for talent and innovation in medical devices.


  • -
Last Untapped Market event

The Last Untapped Market Event

Family Office Networks and ABS are holding a talk at Flemings Steakhouse in Newport Beach.  Charles Laverty will be speaking at this event titled The Last Untapped Market.

The discussion will be about how ABS platform is the only platform that covers all stenting.


  • -

Family Office Networks Partners With ABS

FON Says The ABS Platform Will Become The “standard of care”

Family Office Networks announced today a partnership with Advanced Bifurcation Systems (ABS) to introduce its family office members to the ABS platform. Calling our platform a “paradigm shift” in interventional cardiology and saying they expect the ABS platform to become the “standard of care” in the $2.5 billion global bifurcation market.

“ABS represents a great opportunity for family office investors who seek to make a real impact on the future of healthcare. We believe ABS is poised to capture a significant part of this $2.5B market as the only true and complete bifurcating stent delivery platform in the market”

Family Office Networks Founder Andrew Schneider.

 


  • -

What is Advanced Bifurcation Systems?

Category : News

Advanced Bifurcation Systems® has disruptive technology for left main heart disease, stenting coronary arteries at their branch points. This platform is a paradigm shift in interventional cardiology.

The ABS® platform is protected by more than 36 issued and 12 pending patents and will become the “standard of care” in the $2.5 billion global bifurcations market.

Read More


  • -
New Heart Technologies in Battle post by Charles Laverty for ABS

Innovative Technologies Fight the World’s Top Killer

Technologies In Battle

Heart disease can strike when least expected. Almost everyone knows someone who has suffered from a heart attack or a stroke. At present, heart disease is still the number one killer in the world. But new technologies hold promise and are likely to revolutionize healthcare.

Mobile health technology is being seen as an affordable way to address risks associated with heart disease such as high blood pressure and excess weight. Studies have shown how patients responded to text messages of advice, support, and motivation, managing to meet their targets faster than control groups.

There is even a smartphone app that is able to measure how much blood the heart pumps with each beat. It can do this as well as an ultrasound.

Analyzing The Eye

Google scientists have found a way to assess the risk of heart disease by using machine learning. They have software that can analyze the back of a patient’s eye and establish the likelihood of a person suffering a cardiac event. This is not being used in clinical settings yet because further research is needed.

The NHS is planning to start using AI to diagnose scans this year. An AI system was developed at John Radcliffe Hospital that makes a possible more accurate diagnosis of scans.

With AI comes the ability to accumulate and analyze great quantities of medical data and improve on existing diagnostic procedures. In turn, patients benefit from receiving the right treatment at the right time which can improve their outlook.

A Simple Day Procedure

Our own dual catheter system has the potential to transform the way bifurcate lesions are treated, turning this into a simple day procedure rather than a complex, risky operation. Once again, the patient will benefit from less downtime and see better results.

The use of these new technologies could have a powerful impact on our lives, increasing life expectancy and reducing heart disease fatalities. They could mean the difference between life and death.


  • -
MaRS Accepted ABS Canada

MaRs Accepts Advanced Bifurcation Systems Canada

Accepted by MaRS

ABS is very excited to be accepted to join MaRS.  MaRS helps entrepreneurs grow their companies with a comprehensive network of partners.

A quote from their site is “MaRS is the world’s largest urban innovation hub, a place where today’s moonshots become tomorrow’s breakthroughs. It’s a launchpad for startups, a platform for researchers and a home to innovators.”

This Canada based company is found in one of the largest most diverse city in the country.  They are uniquely located to lead in change.  MaRS brings the communities of researchers, social scientists, business experts, and educators all together.

Our company is proud to join these ranks and our full article can be found here.